Cervical cancer is a major cause of death, and the second most frequent cancer in women worldwide. 1 Many studies have indicated a causal relation between genital human papillomavirus (HPV) infections and cervical cancer. High risk HPV genotypes have been detected in almost 100% of all cervical cancers, and the process of HPV mediated carcinogenesis has been partly clarified. Because HPV infections are so widespread in the general population and because HPV-immortalized cell lines are generally not tumorigenic, other factors in addition to HPV infections, such as the host immune response to HPV infections, are thought to have a role in controlling both HPV infections and HPV-related neoplasm. 2 This is supported by the observation that an ineffective cellular immune response, as immunocompromised individuals with human immunodeficiency virus, is associated with an in-2005 10 7 , 110-744 28 02) 2072-3511․ 02) 762-3599
creased incidence of HPV-related disorders. 3 Type 1 cytokines, such as interferon gamma and IL-2, increase cell mediated immune responses and are considered to be beneficial for antitumor immunity. Type 2 cytokines, such as IL-4, IL-5, and IL-10, inhibit Type 1 responses and promote humoral responses. 2, 4 Of these Type 2 cytokines, IL-4 is intriguing in that high affinity IL-4R is expressed on a variety of solid tumor cells, including renal cell carcinoma, squamous cell carcinoma of head and neck, lung, and gastric carcinoma. [5] [6] [7] [8] [9] IL-4 was found in cervical cancer cell lines and known to promote cervical carcinogenesis and overexpressed parallel to the progression from cervical intraepithelial neoplasia to cervical cancer. 2, 10 Signaling through the receptors of IL-4 has been suggested to have some biologic effects on theses tumor cells, such as production of IL-6. [5] [6] [7] [8] IL-4R gene has several types of polymorphic sites.
Genetic variants of IL-4R polymorphisms of Ile50Val were known to upregulate receptor response to IL-4 which is associated with atopy. 11 The result supports the idea that The sequences of the primer and probe used in this study are listed in Table 1 . Primer and probe were designed using the Primer Express software version 1.5 (Applied Biosystems, Foster City, CA). Detection system was ABI PRISM 7900 HT. Table 3) .
Subanalyses of the patients with cervical cancer were conducted according with clinical stage, histologic type, lymph node status, and parametrial invasion status (Table   4 ). There was no statistically significant interaction between these polymorphisms and these parameters.
Although we sought to determine whether IL-4R gene polymorphisms of Ile50Val influenced cervical cancer risk, we did not observe any association of Ile50Val with cervical cancer risk.
Some studies have showed the association of IL-4 and cervical cancer. A shift in cytokine, especially IL-4, production patterns was reported to occur during the progression from CIN to invasive cervical cancer. 12 An increased immunohistochemical expression of intratumoral IL-4 in HGL compared with LGL or normal cervix, and IL-4 mRNA was more expressed in cervical cancer biopsies than in normal or CIN biopsies without significant. 13, 14 In many cancers, including cervical cancer, ovarian cancer, renal cell carcinoma or colorectal carcinoma, IL-4 expression is also detected in biopsies. 4, [15] [16] [17] With respect to serum concentrations of interleukins, median serum IL-4 in healthy women was higher than in patients with cervical cancer. 10 The serum level of IL-4 was not different between patients with CIN and the healthy women. 18, 19 However, serum IL-6, IL-8, and IL-10 were elevated in patients with cervical cancer and correlate with progression of the disease. 20 However, the production of IL-6 may be associated with the signaling through the receptors of IL-4. [5] [6] [7] [8] The switch form type 1 to type 2 cytokines described in many human cancers mainly depends on upregulation of IL-6 and IL-10 and not IL-4. 21 In CIN, the level of IL-10
was increased compared to the controls. 17, 22 The increased serum level of IL-6 was observed both in CIN and cervical cancer. Furthermore, IL-6 itself has a role in carcinogenesis of uterine cancer. 23, 24 The Hardy-Weinberg equilibrium suggested no deviation in recruiting the controls. However, the result of this study had low calculation power and large numbers of samples were needed to confirm the lack of association of polymorphisms of IL-4R and risk of cervical cancer. Comparing 33, 34 However, in the viewpoint of immunosurveillance of tumor, Stat 6-deficiency was suggested as a potent strategy for immunotherapy. 35 This is the first article which explored the association between the polymorphisms of IL-4R gene, Ile50Val, and cervical cancer. In summary, we did not provide any evidence that Korean women with the polymorphisms of Ile50Val in IL-4R genes had an altered risk of development and progression of cervical cancer.
